Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Rubin

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Emergency Radiology|September 3, 2025
Afterhours diagnostic radiology in the USA: radiologists' views on imaging volumes, compensation, work-from-home, and compensatory time-offYelim Lee, Tarek Hanna, Thomas Ptak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as MonotherapyMark Ayers, Michael Nebozhyn, Razvan Cristescu, et al.
Addictive Behaviors Reports|June 14, 2019
Learning functions in short-term cocaine usersDanusha Selva Kumar, Elysia Benedict, Olivia Wu, et al.
Cancer Research|February 11, 2011
eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206Yan Cheng, Xingcong Ren, Yi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumorsScot Ebbinghaus, Eric Rubin, Evan Hersh, et al.
Cancer Chemotherapy and Pharmacology|May 28, 2003
A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignanciesA Thalasila, Elizabeth Poplin, J Shih, et al.
The Journal of Biological Chemistry|June 21, 2023
Correction: Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of actionKatharina Weinhäupl, Marcos Gragera, M Teresa Bueno-Carrasco, et al.
BMC Molecular Biology|May 1, 2010
Deficiency of the dual ubiquitin/SUMO ligase Topors results in genetic instability and an increased rate of malignancy in miceHenderson Marshall, Mantu Bhaumik, Hana Aviv, et al.
The Journal of Biological Chemistry|October 8, 2022
Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of actionKatharina Weinhäupl, Marcos Gragera, M Teresa Bueno-Carrasco, et al.
The New England Journal of Medicine|January 10, 2022
<i>NEJM Evidence</i> - A New Journal in the NEJM Group FamilyChana A Sacks, C Corey Hardin, Sharon-Lise Normand, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Emergency Radiology|September 3, 2025
Afterhours diagnostic radiology in the USA: radiologists' views on imaging volumes, compensation, work-from-home, and compensatory time-offYelim Lee, Tarek Hanna, Thomas Ptak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as MonotherapyMark Ayers, Michael Nebozhyn, Razvan Cristescu, et al.
Addictive Behaviors Reports|June 14, 2019
Learning functions in short-term cocaine usersDanusha Selva Kumar, Elysia Benedict, Olivia Wu, et al.
Cancer Research|February 11, 2011
eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206Yan Cheng, Xingcong Ren, Yi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumorsScot Ebbinghaus, Eric Rubin, Evan Hersh, et al.
Cancer Chemotherapy and Pharmacology|May 28, 2003
A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignanciesA Thalasila, Elizabeth Poplin, J Shih, et al.
The Journal of Biological Chemistry|June 21, 2023
Correction: Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of actionKatharina Weinhäupl, Marcos Gragera, M Teresa Bueno-Carrasco, et al.
BMC Molecular Biology|May 1, 2010
Deficiency of the dual ubiquitin/SUMO ligase Topors results in genetic instability and an increased rate of malignancy in miceHenderson Marshall, Mantu Bhaumik, Hana Aviv, et al.
The Journal of Biological Chemistry|October 8, 2022
Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of actionKatharina Weinhäupl, Marcos Gragera, M Teresa Bueno-Carrasco, et al.
The New England Journal of Medicine|January 10, 2022
<i>NEJM Evidence</i> - A New Journal in the NEJM Group FamilyChana A Sacks, C Corey Hardin, Sharon-Lise Normand, et al.
Pageof 10